Human longevity: 25 genetic loci associated in 389,166 UK biobank participants by Pilling, LC et al.




For centuries there has been great interest in factors 
enabling some individuals to live to very old ages. 
Extreme longevity can be achieved in animal models by 
knocking out many specific genes [1].  In  humans there  
 
is a growing number of inherited (germline) genetic 
variants linked to overall [2] and longer human lifespan 
[3,4] in conventional genome wide association studies 
(GWAS), and in studies weighted for the large numbers 
of previously reported variant associations with related 
diseases and traits [5, 6]. 
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age  genetic  risk  score  associated  with  parental  survival  in  the  US  Health  and  Retirement  Study  and  the
Wisconsin  Longitudinal  Study  and  with  having  a  centenarian  parent  (n=1,181)  in  UK  Biobank.  The  results
suggest  that  human  longevity  is  highly  polygenic  with  prominent  roles  for  loci  likely  involved  in  cellular
senescence and inflammation, plus lipid metabolism and cardiovascular conditions. There may also be gender
specific routes to longevity.  
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Human longevity or lifespan has moderate heritability 
in twin studies, estimated at 20-30% [7], with health 
related behaviors, environmental exposures and chance 
likely explaining much of the remaining variability. 
GWAS have mostly studied general survival or 
compared longer lived individuals (e.g. aged 80+, 90+ 
or centenarians) to younger controls. An alternative 
approach to studying older individuals themselves is to 
study parental longevity. Biological offspring of longer 
lived parents inherit a combination of parental genetic 
variants, and tend to remain healthier and live longer 
than the offspring of shorter lived parents [8]. In the US 
Health and Retirement Study (HRS), we found that 
mortality in offspring declined progressively with later 
parental ages of death [9]. In addition, offspring of longer 
lived parents had progressively lower incidence of 
cardiovascular disease and cancers, plus reduced rates of 
cognitive impairment [10]. These findings were replicat-
ed in 186,151 non-adopted UK Biobank participants [11]. 
Statistical associations of mothers’ and fathers’ attained 
ages with offspring health outcomes in HRS were 
additive. These findings suggest that combined parental 
longevity is a quantitative trait of slower aging, likely 
with a significant genetic component. 
 
We [12] and separately Joshi et al. [13] previously 
undertook a GWAS of parental longevity in the first one 
third UK Biobank (UKB) participants aged 55-70 [12]. 
We determined the percent of variance of parental age 
at death explained by the directly genotyped variants on 
the UKB arrays (n=845,997): the variance attributed 
was greatest for the sum of normalized mother’s and 
father’s age at death (10.2%, SD=1.26%) and smaller 
for mothers (6.08% SD=1.21%) and fathers (5.79% 
SD=1.23%) separately.  
 
In the current analysis we aimed to extend our previous 
GWAS to include data from the newly available fully 
genotyped UKB cohort, essentially tripling our previous 
sample size. We aimed to identify all common genetic 
variants (prevalence ≥0.1%) associated with longer 
parental lifespan. We studied combined parents’ attained 
ages but also tested associations with both parents having 
longest 10% survival, to establish whether variants were 
associated with long life rather than early death. We also 
examined mothers’ and fathers’ age of death separately. 
We also tested a combined genetic risk score of our 
findings in two US aging cohorts, the HRS and the 




Subjects meeting inclusion criteria (Table 1) were 
389,166 UK Biobank participants of European descent 
with data recorded on parents’ current ages or parents’ 
ages of death (n=181,048 had one or more living 
parents). GWAS analyses had >99% power to detect an 
allele of 1% minor allele frequency, accounting for 
0.1% of the variance in the phenotype, after correction 
for multiple statistical testing (alpha=5x10-8). Variants 
with minor allele frequencies of >0.1 were included.   
 
GWAS of parental attained age  
 
We examined associations with both parents’ combined 
attained ages (including ages of living parents), using 
Martingale residuals from Cox’s proportional hazards 
regression models, following the approach used by 
Joshi et al. [13]. In this analysis we found 10 loci 
associated at genome wide significance (p<5x10-8) 
(Table 2; Supplementary Table 1 for details of all 
significant variants; full results available to download 
https://doi.org/10.6084/m9.figshare.5439382.v1).  
 
Associations with APOE related rs429358 (p=5x10-22) 
variant were confirmed, as were associations with the 
CHRNA3/5 (nicotinic acetylcholine receptor) locus 
(rs1317286, 33.2% minor allele frequency, p=1.2x10-
26). Associations were also found for six other loci 
already implicated in disease specific GWAS; the 
strongest association was with rs55730499 (8% 
frequency, p=1.7x10-18) in an intron of LPA gene, 
associated with lipoprotein A and LDL cholesterol 
levels, plus CAD [14]. Variants in the 9p21 region, 
which includes CDKN2B-AS1 (ANRIL) and 
CDKN2A/B, were also associated (lead SNP rs1556516, 
49.8% frequency, p=4.7x10-16); this locus is involved in 
cellular senescence and associated with myocardial 
infarction and peripheral vascular disease [14]. Genetic 
variants across the 9p21.3 locus have previously also 
been associated with type-2 diabetes and cancers [14] 
and in longevity/survival analyses (see below), but only 
the CAD-associated loci were associated  (p<5x10-8) with 
parent’s lifespan (Figure 2; Supplementary Table 2).  
 
Associations with parents’ attained age were also 
present for rs7137828 (48.3% frequency, p=3.4x10-14) 
near ATXN2, coding for Ataxin-2 which is involved in 
endocytosis and is associated with blood traits and 
autoimmune disease [14]. SNPs in LD (R2=0.91) with 
rs7137828 include rs3184504 (48% frequency, p=4x10-
8), a missense variant in the SH2B3 gene, associated 
with blood pressure, maternal birth weight, TNF-α 
levels, colorectal cancer, Inflammatory Bowel Disease, 
LDL cholesterol levels and stroke [14]. Other known 
loci included rs28383322 (located between HLA-DRB1 
and HLA-DQA1, p=5.3x10-11), previously associated 
with atopic dermatitis; rs17514846 (located in an intron 
of FURIN, p=7.1x10-10), previously associated with 
blood pressure; and rs602633 (located between CLESR2 
and PSRC1, p=2.7x10-8), previously associated with 
CAD and LDL [14]. 







































Two associations were discovered for novel variants not 
previously linked in GWAS to other traits or diseases; 
rs7844965, located in an intron of EPHX2 (23.2% 
frequency, p=7.7x10-9), and rs61978928, located in the 
3’ UTR of gene PROX2 (31.2% frequency, p=2x10-8). 
 
A parents’ attained age genetic risk score in 
independent cohorts 
 
We calculated a genetic risk score (GRS) combining the 
10 attained parental age associated variants, weighted 
by the estimated effect sizes. Genotyped samples of 
European descent from the Health and Retirement 
Study (HRS, n=12,940 in genetic analyses) and the 
Wisconsin Longitudinal Study (WLS, n=8,952 from 
6,683 families) were too small to test individual variant 
associations: the sample size needed for 80% power to 







































parents' lifespan at p<0.05 (R2=0.0005 in UK Biobank) 
is 15,598, but much larger samples were required for 
the smaller-effect variants discovered in UK Biobank. 
We therefore tested the parents’ attained age GRS; the 
sample size needed for an 80% chance of detecting an 
association of this magnitude (R2=0.002 in UKB) with 
p<0.05 was 3,924. In Cox’s proportional hazards 
survival models against both dead and alive parents 
attained ages in HRS (n=12,345, number of 
events=9,809), increasing GRS was associated with 
longer survival (mortality Hazard Ratio=0.961, 95% 
CIs=0.942 to 0.980, p=6x10-5, adjusted for offspring 
age, sex, and genetic principal components 1-5). In the 
WLS (n=7,437, number of events=6,683, errors 
clustered by family), increasing GRS was associated 
with longer survival (mortality Hazard Ratio=0.963, 95% 
CIs=0.938 to 0.988, p=4x10-3, adjusted for age at saliva 
collection, sex, and genetic principal components 1-5). 
Table 1. Summary statistics for 389,166 UK Biobank participants of European descent with genetic and 
parental age data. 
    n min - max mean (SD) 
Age of study participant (years) 389,166 40 - 73 56.66 (8) 
BMI (Kg/m2) 387,951 12.12 - 74.68 27.31 (4.73) 
  
Mother's age at death (years) 246,941 56 - 107 77.39 (9.77) 
Mother's age if alive (years) 165,996 60 - 105 78.58 (8.15) 
  
Father's age at death (years) 317,652 46 - 106 72.18 (11.05) 
Father's age if alive (years) 97,659 60 - 103 78.02 (7.37) 
  
Combined parents’ age at death 
Years (average) 208,118 51 - 101 75.41 (7.79) 
Sum of z-scores 208,118 -3.12 - 3.31 0.01 (1) 
Combined parents’ age (alive or dead) 
Years (total) 389,166 102 - 202 151.57 (14.98) 
  
    n %   
Sex 
Females 212,672 54.65 
Males 176,494 45.35 
Smoking status 
Never 212,833 54.87 
Former 136,647 35.23 
Current 38,414 9.9 
Highest education level attained 
None 62,519 16.21 
Secondary 65,585 17 
College-level 71,048 18.42 
Professional / University 186,572 48.37 
Both parents top 10% survival 
No (both died <80) 79,767 91.74 
Yes (≥90 mothers, ≥87 fathers) 7,182 8.26 
Combined parents’ age (alive or dead) 
Either alive 181,048 46.52 
Both dead 208,118 53.48 




































Functional implications and pathways analysis 
 
We investigated effects of the parents’ attained age 
SNPs on expression of genes in multiple tissues, such as 
whole blood [15], using the FUMA tools [16]. 
Expression of 53 genes were associated, including 8 of 
the 10 nearest genes to the variants identified above 
(Supplementary Table 5 & 6).  
 
In MAGENTA gene-set analysis, only two pathways 
were significantly enriched after correction for multiple 
testing, both related to nicotinic acetylcholine receptor 
binding and downstream events (Supplementary Table 
4). 
 
Sensitivity analyses of combined parents’ attained 
age analyses  
 
We generated QQ plots for all GWAS (Supplementary 
Figure 2) and observed some genomic inflation 




































tent with human longevity being highly polygenic, but 
perhaps also representing some effect of relatedness in 
inflating results. The BOLT-LMM software used for 
analysis accounts for relatedness in the methods, but we 
investigated further; the 10 variants associated with 
attained parental age were tested in Cox proportional 
hazards (CoxPH) models against parents’ attained age, 
to assess whether the associations observed with rank-
normalized Martingale residuals were robust. These 
models also excluded related (≥3rd-degree) participants, 
leaving a reduced sample size of n=326,864, including 
n=153,101 with censored data due to at least one parent 
still being alive. Five of the 10 loci remained genome 
wide significant (p<5x10-8) in these models; APOE, 
CHRNA3, LPA, ANRIL, and ATAXN2/SH2B3 (Supple-
mentary Table 3) with the remaining five directionally 
consistent and associated at p≤3.1*10-6.  
 
We performed sensitivity analyses only including 
parents who had died (Figure 1B; Table 2), as the ages 
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an incomplete measure of their longevity. This analysis 
included a smaller sample size of n=208,118 UKB 
participants with both parental ages of death known. 
The same five of the ten loci reported above remained 
genome-wide significant (APOE, CHRNA3, LPA, 
ANRIL, and SH2B3) with the remaining loci remaining 
nominally significant. Two additional variants not 
identified in the previous analysis emerged as 
candidates for follow-up: rs1627804 (32% frequency, 
p=4x10-8), in an intron of BEND3, a transcriptional 
repressor which associates with the NoRC (nucleolar 
remodeling complex) complex and playing a key role in 
repressing ribosomal DNA transcription; and 
rs146254978 (2% frequency, p=4.6x10-8), located in an 









































GWAS of both parents achieving longest 10% 
survival  
 
We next tested binary associations with having both 
parents surviving to the longest 10% of lifespans, using 
sex-specific age-at-death cut-offs (father ≥87, mother 
≥90, including living parents aged over these age cut-
offs), to assess whether associations were attributable to 
longer lives rather than early deaths. This analysis con-
firmed associations (Figure 1C; Table 1) with variants 
in the APOE, CHRNA3, LPA and CDKN2B-AS1, with a 
suggestive association with ATXN2 (p=3.4x10-6). Two 
further loci just reached significance in this analysis: 
rs28926173 (4.7% frequency, p=2.3x10-8) in an intron 










































  P-values for phenotype: 
Effect for the analysis in 
bold 















age A1F Beta SE Implicated gene(s) 
Combined parents’ age results       
Common & in GWAS catalogue of findings       
rs602633 1 109821511 T G 2.7E-08 2.9E-03 2.4E-03 2.1E-03 3.6E-09 0.217 -0.0150 0.0027 CLESR2 ... PSRC1 
rs28383322 6 32592796 C T 5.3E-11 9.8E-03 2.0E-04 3.5E-09 2.0E-04 0.783 0.0182 0.0028 
HLA-DRB1… 
HLA-DQA1 
rs55730499 6 161005610 C T 1.7E-18 5.4E-11 2.7E-08 5.5E-10 5.9E-17 0.920 -0.0361 0.0041 LPA 
rs1556516 9 22100176 G C 4.7E-16 1.5E-10 2.5E-08 8.7E-05 1.3E-20 0.502 -0.0181 0.0022 
CDKN2B-AS1 
(ANRIL) 
rs7137828 12 111932800 C T 3.4E-14 3.1E-08 3.2E-06 2.2E-07 2.7E-12 0.483 0.0170 0.0022 SH2B3 / ATXN2 
rs1317286 15 78896129 A G 1.2E-26 1.8E-11 4.0E-09 2.1E-07 1.5E-31 0.668 -0.0254 0.0024 CHRNA3 
rs17514846 15 91416550 C A 7.1E-10 6.6E-07 2.0E-04 7.8E-04 1.2E-07 0.530 -0.0139 0.0023 FURIN 
rs429358 19 45411941 T C 1.4E-74 5.0E-22 7.1E-46 1.3E-68 1.9E-28 0.845 -0.0566 0.0031 APOE / APOC1 
Common       
rs1627804 6 107400428 C A 1.1E-04 4.0E-08 4.5E-06 5.7E-03 2.4E-04 0.684 0.0197 0.0035 BEND3 
rs7844965 8 27442064 G A 7.7E-09 1.5E-04 6.0E-04 4.9E-04 2.2E-07 0.768 0.0154 0.0027 EPHX2 
rs61978928 14 75321714 T C 2.0E-08 7.7E-05 3.3E-07 1.0E-04 1.9E-07 0.688 0.0136 0.0024 PROX2 
rs28926173 18 13886719 G A 6.4E-06 2.4E-05 2.3E-08 2.4E-04 2.5E-02 0.953 -0.0264 0.0047 MC2R 
Rare (<2%)       
rs146254978 1 74867799 T C 2.1E-02 4.6E-08 1.9E-03 4.3E-01 3.0E-04 0.980 -0.0692 0.0126 FPGT / TNNI3K 
rs139137459 11 119269958 G A 5.3E-03 1.1E-01 2.7E-08 3.0E-02 3.1E-02 0.996 -0.0906 0.0162 USP2-AS1 
Loci only emerging in mothers’ analysis       
rs3130507 6 31147476 G A 3.5E-06 6.1E-02 8.9E-01 2.1E-10 2.4E-01 0.720 -0.0155 0.0024 PSORS1C3 … [x] 
13:31871514 13 31871514 T G 5.6E-04 4.5E-01 7.0E-01 4.7E-08 3.4E-01 0.995 0.0979 0.0180 B3GALTL 
rs61949650 13 64836488 T C 4.2E-05 1.5E-03 1.5E-03 2.9E-08 6.7E-01 0.938 0.0251 0.0045 (intergenic) 
Loci only emerging in fathers’ analysis       
rs3131621 6 31425499 A G 8.9E-08 1.9E-02 4.8E-01 3.5E-05 3.6E-08 0.629 -0.0124 0.0022 MICA … MICB 
rs13262617 8 59838133 A G 9.6E-03 7.3E-03 1.3E-01 8.1E-01 3.1E-08 0.970 0.0360 0.0064 TOX 
rs61905747 11 113639842 A C 3.6E-05 3.5E-02 7.0E-02 2.2E-01 5.5E-09 0.809 -0.0160 0.0028 ZW10 
rs74011415 15 47660194 G A 7.0E-06 3.9E-02 2.6E-02 5.0E-02 1.4E-08 0.881 -0.0192 0.0034 SEMA6D 
rs12461964 19 41341229 A G 1.8E-04 1.5E-01 7.8E-01 4.8E-01 8.2E-09 0.504 -0.0126 0.0022 EGLN2 … CYP2A6 
rs74444983 19 45745607 T C 4.1E-05 9.1E-03 1.1E-01 6.9E-02 9.1E-09 0.741 -0.0143 0.0025 
EXOC3L2 … 
MARK4 
rs6108784 20 10964366 T C 7.7E-04 4.3E-01 5.7E-02 7.8E-01 1.2E-10 0.586 -0.0143 0.0022 C20orf187 
rs2273500 20 61986949 T C 4.4E-07 8.9E-02 1.8E-01 3.8E-03 1.5E-08 0.856 -0.0176 0.0031 CHRNA4 





Implicated  gene(s)  =  Variants  in  locus  usually  intronic,  or  exonic  (indicated  by  underlining).  If  two  genes  separated  by  dots,  the  SNP  is 
intergenic 
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2.7x10-8) in an intron of USP2-AS1 (near USP2). The 
MC2R variant was associated at p=6.4x10-6 with 
parents’ attained age, but the USP2-AS1 variant had a 
low population frequency (0.4%) and was not 
significant in the continuous trait analyses. 
 
Genetic risk score associations with centenarian 
status and offspring health status in UKB 
 
There were 691 UKB participants with a centenarian 
mother (the longest lived 0.1% of maternal deaths in the 
sample), and 747 with a father aged ≥98 years (the 
corresponding age cut-off of longest lived 0.1%); only 
five participants had both parents in the longest lived 
0.1%. Although this relatively small group (0.3% of the 
full attained age sample) were included in the discovery 
analysis, we tested the GRS for association with having 
a centenarian parent (in the un-related UK Biobank 
participants, n=1,181), against controls whose (both) 
parents died before age 80 (n=66,280). Increasing 




































having a centenarian parent (OR per standard de-
viation of GRS=1.193, 95% CIs=1.130 to 1.260, 
p=3.0x10-10).  
 
GWAS of mothers’ and fathers’ age at death 
separately 
 
We tested for parental gender differences by conducting 
separate GWAS for mothers’ and fathers’ attained ages 
(including living parents). Eleven additional genetic 
variants were identified, three only associated with 
mother’s age at death, eight associated with father’s age 
at death (Table 2). Results included variants previously 
associated with the autoimmune diseases psoriasis and 
idiopathic membranous nephropathy (for mothers), and 
an independent nicotine-dependence locus on 
chromosome 20 for fathers. Novel gene-longevity 
associations included genes MICA/B (a locus previously 
linked to autoimmune conditions rheumatoid arthritis 
and multiple sclerosis), TOX, ZW10, SEMA6D, 





































Figure  2.  LocusZoom  plot  of  the  CDKN2A/B/ANRIL gene  cluster  and  known  disease  variants.  Known  disease‐
associated genetic variants have been highlighted  in the 9p21.3 region,  in addition to the  lead SNP  identified  in our analysis.
Association p‐values indicate the strength of association with parents' attained age. The variants known to influence coronary
artery disease  (CAD) and  related‐traits are  those most‐associated with parents’ attained age. Variants previously associated
with  cancer are markedly  less associated with parents’ attained age, with  type‐2 diabetes variants not associated  (p>0.05).
Details, including references, are included in Supplementary Table 2. 



























Comparison with recently reported GWAS analyses 
of longevity 
 
A recent large analysis by Joshi et al. [2], with up to 
294,998 participants in their analysis of European 
parents’ attained age, included the first third of UK 
Biobank genotyping data plus 26 other cohorts. For 
survival past age 40 years, associations were confirmed 
for APOE and CHRNA3/5, plus novel associations with 
overall longevity (deaths or survival to age 40 years and 
over) with HLA-DQA1/DRB1 and LPA, and with 
replication of CDKN2A/B and SH2B3. While these 
results overlap with our attained age analysis, they also 
reported an association with FOXO3A variants, but we 
found no significant associations for this locus (p>0.01) 
(see Supplementary Table 2 for details). No analyses of 
longer or extreme survival were reported.  
 
McDaid et al. [6] undertook a Bayesian association scan 
of general lifespan (in the first third of UK Biobank), 
weighted for 58 disease related GWAS studies, and 
identified 16 individual variants at genome wide 
significance. Of these, four (LPA, CDKN2BAS, 
CHRNA5 and APOC1) reached conventional GWAS 
significance in our analyses, and CELSR2 only reached 
significance for mothers’ age at death.  
  
While the above studies focused mainly on overall 
lifespan, for aging research survival to extreme ages is 



























gevity, Fortney et al. used samples including 801 
centenarians and 5406 subjects aged 90 plus. Disease 
GWAS results were used to weight genetic variants, 
using a false discovery rate of 10% [5], at which 
associations with APOE, SH2B3/ATXN2, ANRIL, LPA, 
and HLA were reported (although only APOE reached 
conventional genome wide significance). Fortney et al. 
also identified variants at KCNT2 and FADS1, which 
were not associated with parents’ attained age in our 
analysis, with the ABO SNP (rs514659) only just 
reaching nominal significance (p=0.015). 
 
A previous meta-analysis comparing older individuals 
(age 80 or 90+) to younger controls reported a genome 
wide association at the 5q33.3 locus, but no significant 
associations were found for the other two loci (p>0.01). 
Various other variants, including in mitochondrial 
DNA, have been suggested as associated with 
longevity. In our GWAS we tested associations with 
mitochondrial variants, plus variants on the X and Y 
chromosomes, using the directly genotyped microarray 
data: none were significantly associated (p>1x10-5) with 
the studied phenotypes.  
 
Disease-associated genetic variants; candidates for 
future work 
 
We investigated genetic variants associated with 
parents’ attained age (p<1x10-5) that have previously 
been associated with other traits for promising 
Table 3. Variants implicated in disease and trait GWAS that were associated with parents’ attained age at near genome wide 
significance (p>1x10‐8 but p<1*10‐5).  
SNP CHR BP A1 A0 A1FREQ BETA SE P Gene Previous associations with locus 
          
rs11552449 1 114448389 C T 0.826 -0.0134 0.0030 6.3E-06 DCLRE1B  Breast Cancer [18] 
rs6689306 1 154395946 A G 0.419 0.0111 0.0023 1.5E-06  IL6R CAD [40] 
rs11126666 2 26928811 G A 0.745 -0.0117 0.0026 4.5E-06  KCNK3 BMI [17] 
rs7593947 2 60704933 A T 0.526 -0.0110 0.0023 1.2E-06  BCL11A Educational attainment [19] 
4:77410318 4 77410318 C A 0.544 0.0100 0.0022 9.4E-06  SHROOM3 Red blood cell count [41] 
rs1986734 4 77420784 C T 0.476 0.0101 0.0022 6.9E-06  SHROOM3 Creatinine [42] 
rs806794 6 26200677 A G 0.728 0.0115 0.0025 5.0E-06 
 HIST1H2BF … 
HIST1H4E Height [43] 
rs4014195 11 65506822 C G 0.656 -0.0108 0.0024 3.7E-06  RNASEH2C … AP5B1 eGFR [20] 
rs633185 11 100593538 G C 0.285 -0.0112 0.0025 8.9E-06  ARHGAP42 DBP, SBP [44] 
rs56289821 19 11188247 G A 0.882 0.0155 0.0035 7.3E-06  SMARCA4 … LDLR CAD [40] 
rs6511720 19 11202306 G T 0.881 0.0165 0.0035 1.8E-06  LDLR LDL [45] 
rs17724992 19 18454825 A G 0.733 0.0124 0.0025 8.6E-07  PGPEP1 BMI [17] 
      
BP = Genomic position, build 37 (hg19), BETA = Effect on outcome with respect to A1 (the effect allele), P = BOLT LMM p‐value 
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candidates for future work and identified 12 
independent signals (Table 3). These included SNPs 
associated with BMI (rs11126666, [17]), breast cancer 
(rs11552449, [18]), educational attainment (rs7593947, 
[19]), and kidney function (estimated Glomerular 
Filtration Rate, rs4014195, [20]), in addition to a variant 




In this analysis we aimed to extend our previously 
published GWAS study of parental longevity to include 
the newly available full UKB data, achieving an 
unprecedented sample size for longevity studies. We 
have confirmed associations with APOE and CHRNA3 
variants, and additionally identified 8 novel genome 
wide significant variants for our principal phenotype of 
combined parents’ attained age, plus several additional 
variants for our related longevity phenotypes. Overall, 
the findings suggest that human longevity is a polygenic 
trait, influenced by large numbers of modest effect 
variants. Many of the variants identified have been 
previously implicated in age-related diseases or traits, 
notably with coronary artery disease and lipid levels. 
Several loci are near genes involved in inflammation, an 
important pathway in the development of biological 
aging [21]. In additional analyses of mothers’ and 
fathers’ attained ages separately we identified 11 
additional genetic variants, three only associated with 
mother’s age at death and eight associated only with 
father’s age at death.  
 
Parental lifespan-associated variants included 
rs1556516, located in an intron of CDKN2B-AS1 
(ANRIL), a long non-coding RNA; variants in this 
region, 9p21.3, have previously been associated with 
CAD, type-2 diabetes, and cancer [14]. ANRIL is known 
to regulate  neighbor tumour suppressors CDKN2A 
(encoding proteins p14arf and p16) and CDKN2B 
(encoding protein p15) epigenetically through directing 
polycomb gene regulators to modify the chromatin state 
[22]. ANRIL therefore plays a key role in regulation of 
cell proliferation and senescence. It is interesting to note 
that removal of CDKN2a expressing senescent cells 
achieved significant rescue of aging phenotypes in mice 
[23]. Intriguingly, the variants in 9p21 associated with 
lifespan are predominantly related to arterial disease 
(coronary and peripheral arterial disease), rather than 
those influencing cancer or type II diabetes risk (Figure 
2). Decreased expression of specific ANRIL isoforms is 
reported to affect expression of ADIPOR1 (adiponectin 
receptor with a role in fatty acid catabolism and 
inflammation), VAMP3 (membrane protein with a role 
in phagocytosis) and C11orf10 (in proximity to genes 
associated with metabolic syndrome) [24]. The lifespan-
increasing allele for the lead SNP (rs1556516-G) is 
known to increase expression of ANRIL [25]; 
atherosclerosis-related phenotypes are associated with 
lower expression of ANRIL, suggesting a causal 
mechanism of action for this SNP on lifespan. 
 
rs11065979 (chromosome 11) is located near the 
ATXN2 gene, which is known to be associated with 
autoimmune disease and blood traits [14]. The variant is 
also highly correlated (R2=0.91) with an exonic variant 
in SH2B3, previously linked to CAD, blood pressure, 
TNF-α, cell counts and colorectal cancer [14]. SH2B3 
encodes the lymphocyte adapter protein (LNK), which 
plays a key role linking inflammation and hypertension, 
particularly in the kidney and blood vessels [26].  
 
EPHX2 is a hydrolase involved in the degradation of 
vasoactive and anti-inflammatory acids, with possible 
function in LDL-cholesterol metabolism [27]. Exonic 
polymorphisms in EPHX2 are associated with coronary 
artery calcification [28]. PROX2 is a transcription factor 
of unknown function implicated in cardiac muscle and 
neuron differentiation by gene ontology [29]. Genetic 
variants in FURIN, a gene located in chromosome 15, 
were previously associated with blood pressure and are 
here associated with parents’ attained age; the protein is 
a widely-expressed membrane-bound protease, and is 
essential for regulatory and effector T-cell function 
[30]. 
 
Other novel genes implicated include MC2R, where the 
rare allele is associated with 15.7% increased likelihood 
of both parents reaching the top 10% of survival. This 
gene encodes the adrenocorticotropic hormone receptor, 
involved in the secretion of cortisol. This pathway is 
key to the stress response, which is regarded as a pillar 
of the aging process [31]. Lack of this functioning 
receptor can result in chronic hormone-imbalance and 
various  conditions, including subclinical Cushing synd-
rome, plus impaired blood sugar regulation and immune 
system function [32]. 
 
For four of the novel parents’ attained age-associated 
variants it is the rare allele that is associated with 
increased lifespan; rs602633 near CLESR2 and PSRC1; 
rs28383322 near HLA-DRB1 and HRL-DQA1; 
rs7844965 in EPHX2; and rs61978928 in PROX2. This 
is unusual, as for the other genetic variants it is the 
common allele that confers the advantage (the rare 
variant tends to be associated with increased disease-
risk, such as CAD). 
 
We have shown that a genetic risk score based on the 10 
variants associated with combined parents’ age of death 
is associated with parental survival in two independent 
US aging cohorts, suggesting that our overall findings 
are robust. In addition to the more common variants 
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identified (i.e. minor allele frequency >1%) there were 
several rarer variants, such as rs139137459 in USP2-
AS1 (0.4% frequency): these associations are less 
certain, as the GWAS significance level of p<5*10-8 
may not be sufficiently rigorous for testing low 
frequency variants. The identified SNPs previously 
linked to GWAS traits (such as a variant in IL6R) have 
a high prior probability and are especially likely to be 
robust.  
 
This study is limited to European ancestry (white 
British) UK Biobank participants, and results may not 
be applicable to other populations. UK Biobank is a 
healthier volunteer study with a sample that was less 
likely to be obese, to smoke or to drink regularly, 
compared to the general population [33], perhaps 
reducing our power to detect variants associated with 
health behaviors, although the sample still contains 
many participants who were exposed to these factors. 
We were not able to verify reported parental ages or 
ages of death, perhaps introducing misclassification.  
Also, ages of birth of deceased parents were not 
recorded, so it is not possible to compare study and 
national cohort survival.  
 
We are limited by the coverage of the available 
genotyping microarray, and have used data on imputed 
SNPs from the Haplotype Reference Consortium panel, 
with imputation using the UK10K reference panel to 
follow. As with all GWAS discovered loci, the 
identification of affected genes is not straightforward, 
but we have followed the convention of highlighting the 
nearest genes, which for 8 of the 10 attained age 
variants was confirmed by the eQTL data.   
 
We studied the normal range of parental ages at death, 
as well as the top end of longevity (top 10% of 
survival), to establish whether associations were driven 
by early deaths. Our longest lived 10% analysis is 
similar in age (87+ years for fathers, 90+ for mothers) 
to those studied in many of the previous GWAS of 
longevity [3,4]. Analyses with bigger samples of those 
attaining extreme ages are needed, but unfortunately our 
sample with extreme surviving parents (e.g. 
centenarians) is too small for GWAS analyses.  
 
In addition to these limitations, our analysis has several 
strengths. Our sample size yielded unprecedented power 
to detect variant associations: indeed the power (>99% 
to detect an allele of 1% minor allele frequency 
accounting for 0.1% of phenotype variance) is sufficient 
to suggest that we have identified all moderate to larger 
effect common genotyped or imputed variants in our 
studied population. Our analyses were undertaken in a 
single cohort: previous longevity GWAS combined data 
from diverse cohorts, which has been suggested as 
explaining difficulties in detecting and replicating 




Replication and extension of the novel associations in 
other large cohorts and in different ancestries is needed, 
especially for variants narrowly achieving genome wide 
significance. The associations identified should be 
examined in future studies of age-related traits and 
disease. More work is needed to characterize the 
variants identified for biological functions; this could 
include epigenetic and gene expression studies, such as 
analysis of allele-specific expression imbalance in 
heterozygote individuals to determine the gene of action 
for genetic variants [35]. The variants identified in our 
analysis may provide useful information for designing 
targeted prevention or precision treatments to promote 
human longevity, perhaps particularly related to targets 




Our analysis of parental longevity involved the largest 
sample size thus far achieved, with ample power 
(>99%) to detect even modest associations. The results 
indicate that human longevity is a polygenetic trait, 
including likely prominent effects involving cell 
senescence, inflammation, autoimmunity and the stress 
response, plus lipid levels and vascular disease. The 
results suggest that the identified variants are involved 
in achieving long lifespans, and are not limited to 
causing early deaths. The results also suggest that there 
may be gender differences in routes to longevity, with 
autoimmune variants being particularly important in 
women. Overall these results are consistent with some 
previous analyses in humans and with certain key 
hallmarks or pillars of the biology of aging. The 
variants identified may be useful for identifying 
targeted prevention and precision treatments for 




Parental age at death and longevity phenotypes 
 
Participants were asked the age at which their parents 
had died (or their current age if still alive). Analyses 
were performed separately on mother’s age at death and 
father’s age at death, and also on a combined 
phenotype. To reduce the effect of higher ages at death 
of mothers (compared to the fathers) we first z-trans-
formed the mothers and fathers age at deaths before 
combining the z-scores into a single summed 
phenotype. Offspring of parents who died prematurely 
were excluded because the cause of death of the 
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participant’s parents was not asked, so we could not 
exclude accidental deaths explicitly. To determine the 
age at death considered to be too young to be part of the 
normal distribution of age-related mortality, we used 
previously described methods to define a  normal dis-
tribution of ages at death for mothers and fathers 
separately, as described previously [9]). In brief, non-
linear least square regression models were used to fit a 
normal curve on age at death data from the modal (M) 
age at death to the oldest ages; the younger (left) half of 
the curve is then imposed, to avoid the severe skewing 
of the distribution caused by the excess of deaths below 
the modal age. The analysis identified the following 
early death cut-points (based on modal age at death 
minus 1 Standard Deviation): mothers 57 years, fathers 
46 years.  
 
In addition, combined parents’ age (including alive 
parents) were derived from Cox’s proportional hazards 
regression models using Martingale residuals, as 
described by Joshi et al. [13]. Events were defined as 
the both parents having died. We also defined a binary 
phenotype by determining the top 10% of age at death 
for mothers (≥90 years) and fathers (≥87 years) 
separately. Controls were participants where both 
parents died before the age of 80. We were able to 
increase the number of “long lived” parents by 
including alive participants beyond the cut-off.  
 
UK Biobank  
 
Between 2006 and 2010, 503,325 volunteers (aged 45 to 
69 years old) were recruited from across the United 
Kingdom to the UK Biobank study [36]. Of these, 
389,166 participants met the inclusion criteria for at 
least one analysis: participants with complete genetics 
data and either date of death of their parents or their 
current age if alive. Participants were excluded if they 
reported themselves as adopted, or whose parents died 
more than 1 standard deviation below the modal age of 
death (mothers <57 years, fathers <46 years). Several 
longevity phenotypes are defined below based on the 
age at death of the participant’s parents. 
 
Genetic data was available on 488,377 UK Biobank 
participants after genotype calling and quality control 
performed centrally by the UK Biobank team [37]. We 
selected 451,447 participants identified as ‘white 
European’ through self-report and verified through 
principal components analysis based on genotypes. 
Briefly, principal components were generated in the 
1000 Genomes Cohort using high-confidence SNPs to 
obtain their individual loadings. These loadings were 
then used to project all of the UK Biobank samples into 
the same principal component space and individuals 
were then clustered using principal components 1 to 4. 
Related individuals were identified through kinship 
analysis, although these participants were included in 
genome-wide analysis using BOLT-LMM (see below), 
those related to the third-degree or closer were excluded 
in sensitivity analyses. 
 
Imputation of 39,235,157 genetic variants from the 
Haplotype Reference Consortium panel was performed 
using IMPUTE4 centrally by the UK Biobank team 
[37]. After filtering for variants with MAF ≥0.1%, 
missingness <1.5%, imputation quality >0.1 and with 
Hardy-Weinberg equilibrium (HWE) P>1x10-6 within 
the white British participants 11,516,125 imputed auto-
somal variants were eligible for the analyses. 
 
We also utilized data directly from the microarrays for 
variants on the X (n=19,381) and Y (n=284) 
chromosomes, and on the mitochondrial genome 
(n=135), which were unavailable in the imputed dataset. 
 
Health and Retirement Study (HRS) 
 
In HRS v2 data, phase 1-3 samples were combined 
(n=15,708) and SNPs were kept if no discordant 
genotype call among duplicate samples (2,315,518 
SNPs). Related or duplicated participants and geno-
typing controls were removed, as well as those with a 
missing call rate equal to or greater than 2%. After the 
sample quality control, 15,454 samples were kept and 
84% of them (n=12,940) were of European descent. 
 
2,075,208 out of 2,315,518 SNPs passed the composite 
filters by the University of Washington (Hardy-
Weinberg equilibrium p-value < 1e-4, missing call rate 
≥ 2%, sex difference in allelic frequency ≥ 2%  and sex 
difference in heterozygosity > 0.3) and had a minor allele 
frequency greater than zero. As recommended, SNPs 
with a minor allele frequency smaller than 2% further 
were removed. At the end, 1,437,608 SNPs were carried 
forward for SNP pruning. The purpose is to choose less 
correlated SNPs for principal components analysis. 
 
The SNP pruning was performed following the 
procedure: a) consider a window of 50 SNPs, b) 
calculate LD between each pair of SNPs in the window, 
c) remove one of a pair of SNPs if the LD is greater 
than 0.5, d) shift the window 5 SNPs forward and repeat 
the procedure. 514,246 SNPs remained after the SNP 
pruning and were used to run principal components 
analysis. As a result, the top 10 principal components 
were used to adjust for ancestry in a regression model. 
Both SNP pruning and principal components analyses 
were performed in PLINK1.9 
 
The samples in the genetic data were mapped to the 
phenotype data of HRS to retrieve parental longevity 
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phenotypes. We used the phenotype data from the most 
recent wave or visit of HRS where parental data was 
missing if the parent died before the last visit. To 
recover the data, we sequentially looked back at the last 
visit until the parental data was available. Father’s and 
mother’s data therefore could be from different visits 
and the participant’s age varied with phenotypes. 
Mothers dying before 61 years and fathers dying before 
46 years were excluded from the analysis, based on the 
same analysis of distribution of ages of death applied in 
UK Biobank. Parent’s age was set to missing if he or 
she was still alive and younger than the child’s age 
+10.   
 
The genetic risk score analysis was conducted in a Cox 
regression model (against combined parents’ attained 
age, alive or dead: derived by summing the z-
transformed mother’s and father’s attained ages) with 
adjustment for age and sex of the participant and the top 
10 principal components.  
 
Wisconsin Longitudinal Study (WLS) 
 
In the WLS saliva samples were collected by mail in 
2006-7 and during in-person interviews in 2011 for 
those who did not mail back samples. Genotyping on 
the Illumina HumanOmniExpress array was completed 
at Johns Hopkins’ Center for Inherited Disease 
Research (CIDR) and data cleaning and imputation was 
performed in collaboration with the Genetic Analysis 
Center at the University of Washington. After quality 
control, there are a total of 9,012 respondents and 
688,596 SNPs available for analysis. The sample has 
4,601 singletons and 2,263 families with more than one 
member genotyped. Only 66 respondents are not of 
European descent.  
 
Imputation of 33,549,349 genetic variants from the 
1000 Genomes Project reference panel (Phase 3) was 
performed using IMPUTE2, with 686,143 study SNPs 
serving as the imputation basis. Of the 10 variants used 
to construct the GRS, two were directly genotyped and 
eight were imputed. 
 
Parent’s age was constructed by subtracting the year of 
birth from the year of death. When the latter was not 
available, the year of the most recent interview was 
used instead and the parent was classified as not dead. 
Mothers dying before 56 years and fathers dying before 
46 years were excluded from the analysis, based on the 
same modelling of distributions of ages of death applied 
in UK Biobank. Parent’s age was also set to missing if 
the disagreement between sibling reports exceeded 10 
years. The analysis phenotype was the standardized sum 
of both parents’ ages and was set to missing if either 
element was not available.  
The genetic risk score analysis was conducted in a Cox 
regression with censored data, adjusting for age at 
saliva collection, sex of the participant and the top 5 
principal components. Standard errors were clustered at 
the family level. Limiting the sample to the primary 




R package ‘pwr’ and function `pwr.f2.test` was utilized 
for power calculations of regression analysis. The 
numerator degrees of freedom was set to 1, significance 
level to 0.05, and power to 0.8.  
 
Genome-Wide Association Study 
 
We used BOLT-LMM v2.2 to model the associations 
between imputed variants (dosages) and each phenotype 
[38], which uses a linear mixed effects model approach. 
We looked at the results for variants with imputation 
quality >0.1, HWE p-values >1x10-6 and minor allele 
frequencies >0.1% in the white/British subset used for 
all analyses. For variants on the X, Y and mitochondrial 
chromosomes only in the directly-genotyped data we 
used Plink (v1.9) [39] in linear (additive) or binary 
(fisher) models, as appropriate, adjusted for the same 
covariates as above including the first 5 principal 
components from FlashPCA. 
 
Pathways Analysis and Functional Annotation 
 
We utilized FUMA (Functional Mapping and Annotation 
of Genome-Wide Association Studies) to investigate the 
genetic variants associated with parents’ attained age 
[16]. In particular, FUMA performs gene-set analysis 
(using MAGMA) to identify pathways enriched amongst 
the significant genes (weighted by the SNP-associations 
in proximity to them). In addition, FUMA searched 
eQTL databases to identify SNPs that significant alter 
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Supplementary Table 1. GWAS results – parents’ age 
at death MARTINGALE. Significant SNPs (p<5x10-8) 
associated with parents’ attained age. 
 
Supplementary Table 2.  Longevity candidate SNPs 
PDF.  Extracted summary statistics for many candidate 
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Supplementary Table 4. MAGENTA gene-set 
enrichment analysis. Results from the gene-set 
enrichment analysis from FUMA (MAGENTA 
methods). 
 
Supplementary Table 5. FUMA eQTL analysis of 
parents’ attained age-associated variants. SNPs 
associated with parents’ attained age that are eQTLs - 
identified by FUMA methods. 
 
Supplementary Table 6. eQTLs summarised. 
Summary of the eQTL association data from FUMA - 
expression of 53 unique genes affected by SNPs 



































































































































Supplementary Figure 2. GWAS QQ plots 3‐5. QQ plots for each of the 5 GWAS performed. 
